研究动态
Articles below are published ahead of final publication in an issue. Please cite articles in the following format: authors, (year), title, journal, DOI.

超级增强子 RNA m6A 促进胰腺导管腺癌中局部染色质可及性和癌基因转录。

Super-enhancer RNA m6A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma.

发表日期:2023 Nov 13
作者: Rui Li, Hongzhe Zhao, Xudong Huang, Jialiang Zhang, Ruihong Bai, Lisha Zhuang, Shujuan Wen, Shaojia Wu, Quanbo Zhou, Mei Li, Lingxing Zeng, Shaoping Zhang, Shuang Deng, Jiachun Su, Zhixiang Zuo, Rufu Chen, Dongxin Lin, Jian Zheng
来源: Epigenetics & Chromatin

摘要:

非编码 RNA N6-甲基腺苷 (m6A) 修饰的生物学功能仍知之甚少。在本研究中,我们描绘了胰腺导管腺癌 (PDAC) 中超级增强子 RNA (seRNA) m6A 修饰的情况,并揭示了 m6A seRNA、H3K4me3 修饰、染色质可及性和癌基因转录的调节轴。我们证明了在 PDAC 中过表达的丝切蛋白家族蛋白 CFL1 作为 METTL3 辅助因子,有助于 seRNA m6A 甲基化形成。增加的seRNA m6A 被阅读器YTHDC2 识别,它招募H3K4 甲基转移酶MLL1 来促进H3K4me3 共转录修饰。具有高水平 H3K4me3 的超级增强子可增强染色质可及性并促进癌基因转录。总的来说,这些结果揭示了 CFL1-METTL3-seRNA m6A-YTHDC2/MLL1 轴在局部染色质状态和基因表达的表观遗传调控中发挥的作用,这增强了我们对超级增强子及其转录本功能的了解。 © 2023。作者获得 Springer Nature America, Inc. 的独家许可。
The biological functions of noncoding RNA N6-methyladenosine (m6A) modification remain poorly understood. In the present study, we depict the landscape of super-enhancer RNA (seRNA) m6A modification in pancreatic ductal adenocarcinoma (PDAC) and reveal a regulatory axis of m6A seRNA, H3K4me3 modification, chromatin accessibility and oncogene transcription. We demonstrate the cofilin family protein CFL1, overexpressed in PDAC, as a METTL3 cofactor that helps seRNA m6A methylation formation. The increased seRNA m6As are recognized by the reader YTHDC2, which recruits H3K4 methyltransferase MLL1 to promote H3K4me3 modification cotranscriptionally. Super-enhancers with a high level of H3K4me3 augment chromatin accessibility and facilitate oncogene transcription. Collectively, these results shed light on a CFL1-METTL3-seRNA m6A-YTHDC2/MLL1 axis that plays a role in the epigenetic regulation of local chromatin state and gene expression, which strengthens our knowledge about the functions of super-enhancers and their transcripts.© 2023. The Author(s), under exclusive licence to Springer Nature America, Inc.